These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Minocycline attenuates experimental colitis in mice by blocking expression of inducible nitric oxide synthase and matrix metalloproteinases. Huang TY; Chu HC; Lin YL; Lin CK; Hsieh TY; Chang WK; Chao YC; Liao CL Toxicol Appl Pharmacol; 2009 May; 237(1):69-82. PubMed ID: 19285099 [TBL] [Abstract][Full Text] [Related]
12. Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice. Elinav E; Waks T; Eshhar Z Gastroenterology; 2008 Jun; 134(7):2014-24. PubMed ID: 18424268 [TBL] [Abstract][Full Text] [Related]
13. Modulation of glycosphingolipid metabolism significantly improves hepatic insulin sensitivity and reverses hepatic steatosis in mice. Bijl N; Sokolović M; Vrins C; Langeveld M; Moerland PD; Ottenhoff R; van Roomen CP; Claessen N; Boot RG; Aten J; Groen AK; Aerts JM; van Eijk M Hepatology; 2009 Nov; 50(5):1431-41. PubMed ID: 19731235 [TBL] [Abstract][Full Text] [Related]
14. Enteral diets enriched with medium-chain triglycerides and N-3 fatty acids prevent chemically induced experimental colitis in rats. Kono H; Fujii H; Ogiku M; Tsuchiya M; Ishii K; Hara M Transl Res; 2010 Nov; 156(5):282-91. PubMed ID: 20970751 [TBL] [Abstract][Full Text] [Related]
15. Si-Ni-San, a traditional Chinese prescription, and its active ingredient glycyrrhizin ameliorate experimental colitis through regulating cytokine balance. Sun Y; Cai TT; Shen Y; Zhou XB; Chen T; Xu Q Int Immunopharmacol; 2009 Nov; 9(12):1437-43. PubMed ID: 19733696 [TBL] [Abstract][Full Text] [Related]
16. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice. Zhao J; de Vera J; Narushima S; Beck EX; Palencia S; Shinkawa P; Kim KA; Liu Y; Levy MD; Berg DJ; Abo A; Funk WD Gastroenterology; 2007 Apr; 132(4):1331-43. PubMed ID: 17408649 [TBL] [Abstract][Full Text] [Related]
17. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. Daniel C; Sartory NA; Zahn N; Radeke HH; Stein JM J Pharmacol Exp Ther; 2008 Jan; 324(1):23-33. PubMed ID: 17911375 [TBL] [Abstract][Full Text] [Related]
18. The water-soluble extract from cultured medium of Ganoderma lucidum (Reishi) mycelia (Designated as MAK) ameliorates murine colitis induced by trinitrobenzene sulphonic acid. Hanaoka R; Ueno Y; Tanaka S; Nagai K; Onitake T; Yoshioka K; Chayama K Scand J Immunol; 2011 Nov; 74(5):454-62. PubMed ID: 21973321 [TBL] [Abstract][Full Text] [Related]
19. Amelioration of immune-mediated experimental colitis: tolerance induction in the presence of preexisting immunity and surrogate antigen bystander effect. Gotsman I; Shlomai A; Alper R; Rabbani E; Engelhardt D; Ilan Y J Pharmacol Exp Ther; 2001 Jun; 297(3):926-32. PubMed ID: 11356912 [TBL] [Abstract][Full Text] [Related]